Core Laboratories Inc. $CLB Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC cut its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 6.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 774,979 shares of the oil and gas company’s stock after selling 49,600 shares during the quarter. Fisher Asset Management LLC owned approximately 1.66% of Core Laboratories worth $12,423,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Quarry LP grew its position in shares of Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after buying an additional 1,599 shares in the last quarter. CWM LLC grew its position in shares of Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after buying an additional 668 shares in the last quarter. Hantz Financial Services Inc. grew its position in shares of Core Laboratories by 124.7% during the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after buying an additional 1,763 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Core Laboratories by 73.3% during the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock worth $83,000 after buying an additional 2,181 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in shares of Core Laboratories by 400.9% during the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock worth $84,000 after buying an additional 5,869 shares in the last quarter. 97.81% of the stock is owned by institutional investors and hedge funds.

Core Laboratories Stock Performance

Shares of CLB opened at $14.02 on Thursday. The stock has a 50 day moving average price of $15.60 and a 200 day moving average price of $16.65. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $646.32 million, a price-to-earnings ratio of 21.57, a price-to-earnings-growth ratio of 2.81 and a beta of 0.99. Core Laboratories Inc. has a 52-week low of $9.72 and a 52-week high of $20.36.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. The firm had revenue of $121.80 million during the quarter, compared to the consensus estimate of $122.99 million. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The firm’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 earnings per share. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Research analysts predict that Core Laboratories Inc. will post 0.56 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Monday, May 11th will be issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Monday, May 11th. Core Laboratories’s dividend payout ratio is 6.15%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a research report on Monday. Weiss Ratings downgraded Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $12.00.

Core Laboratories Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.